QUESTIONS / ANSWERED FROM THE RECORD
Semaglutide, question by question.
Direct answers drawn from the trials, each tied to a source. No advice, no dosing for individuals.
Can semaglutide help fatty liver disease (MASH)?
Yes, by the trial evidence. In the ESSENCE phase-3 trial of biopsy-confirmed MASH with stage 2-3 fibrosis, once-weekly semaglutide 2.4 mg resolved steatohepatitis without worsening fibrosis in 62.9% of participants versus 34.3% on placebo, and improved fibrosis in 36.8% versus 22.4% [8]. The benefit was confirmed on liver biopsy. This anchored the 2025 MASH indication.
Will semaglutide reduce belly fat?
The trials measured total body weight, not belly fat specifically. In STEP 1, once-weekly subcutaneous semaglutide 2.4 mg produced a mean body-weight change of -14.9% versus -2.4% with placebo over 68 weeks in adults with overweight or obesity without diabetes [1]. Exploratory analyses also reported reduced waist circumference and improved cardiometabolic risk markers [3].
What is semaglutide?
Semaglutide is a peptide medicine — a 31-amino-acid copy of the gut hormone GLP-1, engineered to last about a week so it can be dosed once weekly by injection or once daily as a tablet [9]. It is approved for type 2 diabetes, chronic weight management, cardiovascular risk reduction, and MASH [23]. In STEP 1, mean body weight fell 14.9% versus 2.4% with placebo [1].
What is semaglutide used for?
Semaglutide is approved for type 2 diabetes, chronic weight management, reduction of major adverse cardiovascular events in adults with established cardiovascular disease and overweight or obesity, and, since 2025, metabolic dysfunction-associated steatohepatitis (MASH) [23]. In its pivotal weight trial, STEP 1, it produced a mean 14.9% body-weight reduction versus 2.4% with placebo [1].
How does semaglutide work?
It mimics the gut hormone GLP-1: it boosts glucose-dependent insulin, suppresses glucagon, and slows gastric emptying, while reaching brain appetite circuits to reduce hunger [4]. In rodents it accessed the brainstem, area postrema, hypothalamic arcuate nucleus, and parabrachial nucleus, cutting food intake and shifting food preference without lowering energy expenditure [4].
How does semaglutide work for weight loss?
Mostly through the brain. Semaglutide reaches appetite-regulating circuits — activating satiety (POMC/CART) neurons and inhibiting hunger (NPY/AgRP) neurons — so people eat less rather than burn more [4]. That mechanism produced a mean 14.9% body-weight reduction in STEP 1 versus 2.4% with placebo over 68 weeks [1].
What is the semaglutide dosage for weight loss?
In the STEP trials the documented subcutaneous schedule titrated upward — 0.25 mg weekly, then 0.5, 1.0, 1.7, reaching 2.4 mg once-weekly maintenance [1]. That regimen produced a mean 14.9% body-weight change versus 2.4% with placebo [1]. This is the dose studied, reported in the third person; it is not a recommendation for any individual.
How many mg is 40 units of semaglutide?
This site does not convert insulin-syringe "units" to milligrams, because that calculation depends entirely on a specific product's concentration and is exactly where compounded-product dosing errors have occurred. Semaglutide is dosed in milligrams per its labeling; a pharmaceutical-sciences review summarizes its structure-based long half-life and once-weekly or once-daily dosing [9]. Unit conversions are a question for a prescriber, not a reading room.
What is compounded semaglutide?
Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than the approved manufactured product. It was permitted during a federally declared shortage and curtailed once that shortage was declared resolved in 2025 [23]. The approved-product trial evidence — including the cardiovascular benefit seen in SUSTAIN-6 (HR 0.74) [2] — was generated with the manufactured product, not compounded preparations.
What are the side effects of semaglutide?
The dominant side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation — mostly mild-to-moderate and transient, concentrated during dose escalation [14]. A safety review reported nausea in roughly one-third of patients and noted increased biliary disease, with thyroid and pancreatic signals unconfirmed [5]; SUSTAIN-6 flagged more retinopathy complications with rapid glucose correction [2].
How long does it take for semaglutide to work?
Effects build gradually as the dose is titrated over weeks; the pivotal weight result was measured at 68 weeks (-14.9% vs -2.4% with placebo) [1]. Appetite changes are often described early, but the schedule climbs slowly for tolerability, and the large weight figures reflect roughly a year of treatment [1]. Timelines vary by person and indication.
How long does semaglutide stay in your system?
Semaglutide's elimination half-life is approximately one week (commonly cited as ~165-168 hours), with effectively complete clearance roughly five weeks after the last dose [9][23]. That long persistence comes from reversible albumin binding via its fatty-acid side chain plus DPP-4 resistance [9], and it underlies both once-weekly dosing and multi-week washout guidance.
What is the half-life of semaglutide?
Approximately one week — commonly cited as about 165-168 hours — for both the subcutaneous injection and the oral tablet [9]. A pharmaceutical-sciences review attributes this structure-based long half-life to the albumin-binding fatty di-acid side chain and DPP-4 resistance [9], which is why the drug clears roughly five weeks after the final dose [23].
Is oral semaglutide as effective as the injection?
A meta-analysis of once-daily oral semaglutide reported efficacy in glycemic control and weight, with cardiovascular outcomes consistent with the GLP-1 receptor agonist class in type 2 diabetes [11]. The oral tablet's challenge is absorption: bioavailability is only about 0.4-1%, which is why strict fasted dosing matters [24]. Higher oral doses were studied to push efficacy further [11].
How long does it take for semaglutide to suppress appetite?
The trials did not clock appetite to a precise hour, but the mechanism is central and the effect is typically described early in treatment. In rodents, semaglutide reached brainstem and hypothalamic appetite circuits and reduced food intake [4]. People commonly report a quieter relationship with food within the first weeks, though this is anecdotal and varies by person.
Why am I not losing weight on semaglutide?
Response varies, and this site cannot advise on any individual case. In STEP 1 the mean change was -14.9%, but that is an average across many people, with a range around it [1]. Weight also tends to plateau as the dose stabilizes, and the drug works by reducing intake, so results track with that mechanism [4]. Specific concerns belong with a prescriber, not a reading room.
Does semaglutide make you tired?
Fatigue is commonly reported by users, especially in the first day or two after a dose and during early weeks, though it is not the dominant trial-level adverse effect. The trial record is led by gastrointestinal events [5], with cardiovascular benefit seen in SUSTAIN-6 (HR 0.74) [2]. Reported tiredness is anecdotal, often linked to eating and drinking too little, and usually eases with time.
Is semaglutide a GLP-1?
Yes. Semaglutide is a GLP-1 receptor agonist — a long-acting analogue of the gut hormone glucagon-like peptide-1 that activates the GLP-1 receptor [9]. That class action is what produced the cardiovascular benefit in SUSTAIN-6 (HR 0.74; 95% CI 0.58-0.95) [2] and underlies its effects on blood sugar, appetite, and the other organs in its record.
Does semaglutide cause hair loss?
Hair shedding appears as a pharmacovigilance signal for semaglutide and tirzepatide [21], but the pattern fits telogen effluvium — reversible, diffuse shedding triggered by rapid weight loss rather than the drug itself. A dermatology study linked telogen effluvium to the magnitude and rate of weight loss [22]. People who report it generally describe it as temporary, in line with that explanation.
How fast does semaglutide work?
Deliberately slowly. The dose is titrated over weeks to limit gut side effects [14], and the headline weight result was measured at 68 weeks: -14.9% versus -2.4% with placebo [1]. Some effects, like a quieter appetite, are described early, but the large numbers in the record reflect about a year of treatment, not days [1].
What is the difference between semaglutide and tirzepatide?
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1); semaglutide activates one (GLP-1). In the SURMOUNT-5 head-to-head trial of adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [7]. Semaglutide, however, carries the broader outcomes record across heart, kidney, and liver [3][6][8].
What is the downside of semaglutide?
Mainly three things. Gastrointestinal side effects dominate and lead discontinuations [5]; the weight tends to return after stopping (a mean regain of ~11.6 percentage points within a year in the STEP 1 extension) [19]; and some lean (muscle) mass is lost along with fat [18]. The cardiovascular benefit is real (SUSTAIN-6 HR 0.74) [2], but the record frames this as a chronic treatment.